-
US drops bid to preserve FIFA bribery convictions
-
Oracle shares dive as revenue misses forecasts
-
'Grateful' Alonso feels Real Madrid stars' support amid slump
-
Arsenal crush Club Brugge to keep 100% Champions League record
-
Venezuelans divided on Machado peace prize, return home
-
Ukraine sends US new plan to end the war as Trump blasts Europe
-
Haaland stuns Real as Arsenal remain perfect in Brugge
-
Superb Simon guides Athletic to PSG draw
-
Arsenal crush Club Brugge to keep 100% record in Champions League
-
Man City edge Real Madrid to leave Alonso on brink
-
US stocks rise, dollar retreats as Fed tone less hawkish than feared
-
Trump says had 'pretty strong words' with Europeans on Ukraine
-
M23 tightens grip on key DR Congo city in 'middle finger' to US
-
US seized 'very large' tanker near Venezuela, Trump says
-
'A little scared': high-school coach Rivers returns to NFL action
-
Divided US Fed makes third straight rate cut, signals higher bar ahead
-
Machado to come out of hiding after missing Nobel ceremony
-
Veteran skier Vonn 'in possibly the best shape' of her life
-
Trump says US seized 'very large' tanker near Venezuela
-
UN sounds alarm over Ukraine war's impact on pregnant women
-
French first lady comments spark feminist backlash
-
Mets slugger Alonso set for Orioles move: reports
-
Divided US Fed makes third straight rate cut on jobs risks
-
Anti-government protest draws tens of thousands in Bulgaria
-
Beyonce, Venus Williams, Nicole Kidman to co-chair 2026 Met Gala
-
Intel sees record EU fine reduced further
-
Burundi says M23 advance in DR Congo a 'middle finger' to the US
-
Czechs greenlight magic mushroom use from 2026
-
US plans to order foreign tourists to disclose social media histories
-
Celtic boss Nancy 'won't waste time' on criticism
-
What's at stake as Yemeni separatists gain ground?
-
Stocks mark time ahead of Fed decision
-
Hollywood meets the world in Sundance line-up
-
Veggie 'burgers' remain on table as EU talks stall
-
French far right sparks debate with proposal to reopen brothels
-
Not lovin' it: McDonald's pulls Dutch AI Christmas ad
-
Earliest evidence of humans making fire discovered in UK
-
Evenepoel to share Red Bull lead with Lipowitz at Tour de France
-
Austrian court rejects Ukraine tycoon's US extradition
-
Instagram users given new algorithm controls
-
M23's advance in DR Congo prompts uncertainty, border closure
-
'Downward spiral': French mother blames social media for teen's suicide
-
US Fed expected to make third straight rate cut despite divisions
-
Daughter of Venezuela's Machado picks up Nobel peace prize in her absence
-
NFL to play regular season games in Munich in 2026 and 2028
-
Tens of thousands petition against Croatia Catholic men's public prayers
-
EU seeks better Spain-France energy links after blackout
-
French special forces helped Benin after attempted coup: military
-
Madeleine McCann's father says 'lucky' to survive media attention
-
Sabalenka says transgender women in WTA events 'not fair'
Bausch Health to Announce Third Quarter 2025 Results on October 29
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
W.Nelson--AT